Ross Bailey J, Savage-Elliott Ian, Wu Victor J, Rodriguez Ramon F
Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana.
Foot Ankle Spec. 2023 Feb;16(1):20-27. doi: 10.1177/1938640020987741. Epub 2021 Jan 20.
There are minimal data comparing complications between ankle arthrodesis (AA) versus total ankle arthroplasty (TAR) for operative management of primary osteoarthritis (OA). This study aimed to compare outcomes following AA versus TAR for primary ankle OA using a large patient database.
Patients who received AA or TAR for primary ankle OA from 2010 to 2019 were queried from PearlDiver. Rates of common joint complications were compared at 90 days, 1 year, and 2 years postoperatively using multivariable logistic regression.
A total of 1136 (67%) patients received AA and 584 (33%) patients underwent TAR. Patients that received AA exhibited significantly higher rates of at least one common joint complication at 90 days (19.3% vs 12.6%; odds ratio [OR] 1.69), 1 year (25.6% vs 15.0%; OR 2.00), and 2 years (26.9% vs 16.2%; OR 1.91) postoperatively. This included higher rates of adjacent fusion or osteotomy procedures, periprosthetic fractures, and hardware removal at each postoperative follow-up (all < .05). Rates of prosthetic joint infection were comparable at 2 years postoperatively (4.3% vs 4.2%; OR 0.91).
The AA cohort exhibited higher rates of postoperative joint complications in the short and medium-term, namely, subsequent fusions or osteotomies, periprosthetic fractures, and hardware removal.
Level III.
关于原发性骨关节炎(OA)手术治疗中,踝关节融合术(AA)与全踝关节置换术(TAR)并发症对比的数据极少。本研究旨在利用大型患者数据库比较AA与TAR治疗原发性踝关节OA后的疗效。
从PearlDiver数据库中查询2010年至2019年因原发性踝关节OA接受AA或TAR治疗的患者。采用多变量逻辑回归比较术后90天、1年和2年常见关节并发症的发生率。
共有1136例(67%)患者接受了AA治疗,584例(33%)患者接受了TAR治疗。接受AA治疗的患者在术后90天(19.3%对12.6%;优势比[OR]1.69)、1年(25.6%对15.0%;OR 2.00)和2年(26.9%对16.2%;OR 1.91)至少发生一种常见关节并发症的发生率显著更高。这包括在每次术后随访时,相邻融合或截骨手术、假体周围骨折和内固定取出的发生率更高(均P<0.05)。术后2年假体关节感染率相当(4.3%对4.2%;OR 0.91)。
AA组在短期和中期术后关节并发症发生率较高,即随后的融合或截骨、假体周围骨折和内固定取出。
三级。